Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regulatory Flexibility Staring Contest: Will Industry Or FDA Blink First?

Executive Summary

FDA may be able to talk in theoretical terms about the flexibility it is afforded for orphan products approvals, but others seem to want more tangible evidence. For its part, the agency wants more than general complaints about its regulations; it wants an open discussion of specific roadblocks.
Advertisement

Related Content

Accelerated Approval Should Be Less 'Wide Open,' Califf Says
Rare Disease Integration Into FDA Reviews Will Grow Under PDUFA VI
Regulatory Flexibility For Rare Diseases: How Do You Routinize Elasticity?
Oral History Of Drug Development: FDA’s Califf Wants Woodcock, Temple To Share Their Stories
Orphan Disclosures Could Increase Under Tweaks Proposed By FDA
Orphan Products Mostly Approved With Regulatory Flexibility, NORD "Catalog" Finds
Orphan Products Mostly Approved With Regulatory Flexibility, NORD "Catalog" Finds
Regulatory Reform: FDA Pushes Back, Asks For Specific Problems To Fix
Woodcock Says Blowing Up Orphan Drug Act Not Advisable In Current Climate
PDUFA V Commitment Letter Front-Loads Guidance, Meeting Milestones

Topics

Advertisement
UsernamePublicRestriction

Register

PS053877

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel